Status:

RECRUITING

Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Lead Sponsor:

Bayer

Conditions:

Endometrial Hyperplasia

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

Researchers are looking for a better way to treat women with nonatypical endometrial hyperplasia (NAEH). Endometrial hyperplasia is a condition where the lining of the uterus (called the endometrium)...

Eligibility Criteria

Inclusion

  • Post-menarchal women (≥18 years) at the time of signing the informed consent.
  • Women with histologically confirmed NAEH independent of their parity or menopausal status.

Exclusion

  • Any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results.
  • Congenital or acquired uterine or cervical anomaly including fibroids, or cervical stenosis that in the opinion of the investigator, would interfere with insertion and/or retention of the intrauterine system (i.e., if they distort the uterine cavity).
  • Use of any long-acting injectable sex-hormone preparations within 6 months prior to the start of study intervention, and /or short acting hormonal medication within 6 weeks prior to the start of study intervention.
  • Pregnancy
  • Participants with either known family or personal history of genetic predisposition to uterine, ovarian or colorectal cancers (e.g. Lynch syndrome).

Key Trial Info

Start Date :

November 24 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 3 2027

Estimated Enrollment :

207 Patients enrolled

Trial Details

Trial ID

NCT06904274

Start Date

November 24 2025

End Date

May 3 2027

Last Update

December 23 2025

Active Locations (80)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 20 (80 locations)

1

UAB Medicine Center for Research in Women's Health

Birmingham, Alabama, United States, 35233

2

Women's Health Alliance of Mobile

Mobile, Alabama, United States, 36604

3

AMR - Mobile, AL

Mobile, Alabama, United States, 36608

4

Velocity Clinical Research - Mobile

Mobile, Alabama, United States, 36608